US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Apimeds Pharmaceutical U.S, Inc.

1.91

+0.280017.18%

Post-market: 1.86-0.0500-2.62%18:22 EDT

Volume:129.80K

Turnover:232.78K

Market Cap:24.02M

PE:-4.66

High:1.91

Open:1.64

Low:1.62

Close:1.63

52wk High:4.03

52wk Low:0.9510

Shares:12.58M

Float Shares:337.50K

Volume Ratio:0.83

T/O Rate:38.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.4100

EPS(LYR):-0.1759

ROE:-144.99%

ROA:-69.29%

PB:2.94

PE(LYR):-10.86

Loading ...

Overview Company News Filings

Apimeds Pharmaceuticals US Challenges Disputed Boardroom Power Shift

BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer

Apimeds Pharmaceuticals US Inc: Vin Menon Continues to Serve as the Company’s Chief Executive Officer

THOMSON REUTERS

Apimeds Pharmaceuticals US:Does Not Recognize Alleged Appointment of Youngjik Cho as One of the Directors Made in Connection With Stockholder Consent

THOMSON REUTERS

Apimeds Pharmaceuticals US plans emergency Delaware Chancery Court action; seeks TRO on disputed board consent

BRIEF-Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board

Corrected-Apimeds Pharmaceuticals (Not 'Apimeds Korea') - Appoints Youngjik Cho as Chairman of the Board - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US Inc - Appoints Mr. Cho as CEO and Mr. Yu as Secretary Effective Immediately - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US Inc - Removes DR. Vin Menon as CEO Effective Immediately - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals- on Mar 20, Removes Elona Kogan, Jakap Koo, Carol O'donnell, Bennett Weintraub as Directors Effective Immediately - SEC Filing

THOMSON REUTERS

Apimeds Pharmaceuticals US removes CEO Vin Menon and CFO Erick Frim; Youngjik Cho takes over as CEO and board chair

Apimeds Pharmaceuticals US readies Delaware Court of Chancery action over Inscobee board takeover attempt

Press Release: Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery

Top Executive Makes Notable Move With American Public Education Stock

Apimeds Pharmaceuticals Sets March Effective Date for Reverse Split

Apimeds Pharmaceuticals US approves 1-for-10 reverse stock split

Apimeds, FDA to Discuss Bee Venom Treatment for Osteoarthritis

Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate

Apimeds Pharmaceuticals and LŌKahi Therapeutics Announce FDA Type C Meeting Scheduled for Lt‑100 (Apitox)

THOMSON REUTERS

Amex Halt Add Info Lst 1.990000

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/APUS/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"APUS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","market":"US","secType":"STK","nameCN":"Apimeds Pharmaceutical  U.S, Inc.","latestPrice":1.91,"timestamp":1774641600000,"preClose":1.63,"halted":0,"volume":129795,"hourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":1.91,"latestTime":"18:22 EDT","volume":262,"amount":488.7077,"timestamp":1774650133459,"change":-0.05,"changeRate":-0.026178,"amplitude":0.026178},"delay":0,"changeRate":0.1717791411042945,"floatShares":337500,"shares":12575983,"eps":-0.41,"marketStatus":"Market Closed","change":0.28,"latestTime":"03-27 16:00:00 EDT","open":1.64,"high":1.91,"low":1.62,"amount":232779.9731235,"amplitude":0.177914,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.41,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774857600000},"marketStatusCode":7,"adr":0,"listingDate":1746763200000,"exchange":"AMEX","adjPreClose":1.63,"postHourTrading":{"tag":"盘后","latestPrice":1.86,"preClose":1.91,"latestTime":"18:22 EDT","volume":262,"amount":488.7077,"timestamp":1774650133459,"change":-0.05,"changeRate":-0.026178,"amplitude":0.026178},"volumeRatio":0.828013},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"APUS\",,,,,undefined,":{"symbol":"APUS","floatShares":337500,"roa":"-69.29%","roe":"-144.99%","lyrEps":-0.175862,"volumeRatio":0.828013,"shares":12575983,"dividePrice":0,"high":1.91,"amplitude":0.177914,"preClose":1.63,"low":1.62,"week52Low":0.951,"pbRate":"2.94","week52High":4.031,"institutionHeld":0,"latestPrice":1.91,"eps":-0.41,"divideRate":0,"volume":129795,"delay":0,"ttmEps":-0.41,"open":1.64,"prevYearClose":1.64,"prevWeekClose":2.06,"prevMonthClose":1.36,"prevQuarterClose":1.64,"fiveDayClose":2.06,"twentyDayClose":1.36,"sixtyDayClose":1.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/APUS\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"APUS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"APUS\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/APUS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"APUS","date":"2025-12-01","current":-4.658537,"percent":0.642384,"low":-37.866629,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"high":-4.754876,"avg":-11.953693,"sd":7.073766,"marketCap":36470350},"quantilePoints":[{"date":"2025-02-21","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-02-28","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-03-05","current":-34.716764,"twenty":-34.716764,"median":-34.716764,"eighty":-34.716764,"marketCap":57120291},{"date":"2025-05-09","current":-18.309826,"twenty":-34.716764,"median":-34.716764,"eighty":-33.299512,"marketCap":25450475},{"date":"2025-05-16","current":-14.148502,"twenty":-34.716764,"median":-34.008138,"eighty":-15.063993,"marketCap":19666276},{"date":"2025-05-23","current":-14.074662,"twenty":-34.716764,"median":-18.309826,"eighty":-14.306662,"marketCap":21054484},{"date":"2025-05-30","current":-13.387434,"twenty":-34.716764,"median":-15.063993,"eighty":-14.061031,"marketCap":20026450},{"date":"2025-06-06","current":-14.702962,"twenty":-34.716764,"median":-14.800251,"eighty":-13.996937,"marketCap":21994367},{"date":"2025-06-13","current":-14.314495,"twenty":-34.716764,"median":-14.564634,"eighty":-14.061031,"marketCap":21413253},{"date":"2025-06-20","current":-13.774354,"twenty":-33.866413,"median":-14.548195,"eighty":-14.0474,"marketCap":20605249},{"date":"2025-06-27","current":-13.296895,"twenty":-33.299512,"median":-14.356338,"eighty":-13.867215,"marketCap":19891011},{"date":"2025-07-03","current":-13.774354,"twenty":-27.303638,"median":-14.27266,"eighty":-13.727614,"marketCap":20605249},{"date":"2025-07-11","current":-14.006506,"twenty":-17.177946,"median":-14.161274,"eighty":-13.727614,"marketCap":20952529},{"date":"2025-07-18","current":-13.851738,"twenty":-15.354982,"median":-14.154888,"eighty":-13.727614,"marketCap":20721009},{"date":"2025-07-25","current":-16.173259,"twenty":-16.219689,"median":-14.161274,"eighty":-13.727614,"marketCap":24193804},{"date":"2025-08-01","current":-13.464818,"twenty":-16.219689,"median":-14.199966,"eighty":-13.727614,"marketCap":20142210},{"date":"2025-08-08","current":-12.14929,"twenty":-16.049445,"median":-14.148502,"eighty":-13.573156,"marketCap":18174293},{"date":"2025-08-15","current":-12.265366,"twenty":-15.710284,"median":-14.056061,"eighty":-13.418388,"marketCap":18347933},{"date":"2025-08-22","current":-7.697345,"twenty":-15.447843,"median":-14.006506,"eighty":-13.015991,"marketCap":28547481},{"date":"2025-08-29","current":-6.307075,"twenty":-15.306558,"median":-13.929122,"eighty":-12.721932,"marketCap":23391328},{"date":"2025-09-05","current":-6.307075,"twenty":-15.146611,"median":-13.929122,"eighty":-12.474303,"marketCap":23391328},{"date":"2025-09-12","current":-6.578348,"twenty":-15.038217,"median":-13.851738,"eighty":-12.234412,"marketCap":24397407},{"date":"2025-09-19","current":-6.205348,"twenty":-14.9276,"median":-13.774354,"eighty":-7.507455,"marketCap":23014048},{"date":"2025-09-26","current":-6.049367,"twenty":-14.889578,"median":-13.773581,"eighty":-6.849619,"marketCap":22435553},{"date":"2025-10-03","current":-5.832349,"twenty":-14.826776,"median":-13.69697,"eighty":-6.578348,"marketCap":21630690},{"date":"2025-10-10","current":-6.307075,"twenty":-14.675296,"median":-13.542202,"eighty":-6.472551,"marketCap":23391328},{"date":"2025-10-17","current":-6.239257,"twenty":-14.561346,"median":-13.50351,"eighty":-6.415584,"marketCap":23139808},{"date":"2025-10-24","current":-5.879822,"twenty":-14.548195,"median":-13.387434,"eighty":-6.358617,"marketCap":21806754},{"date":"2025-10-31","current":-6.917438,"twenty":-14.538909,"median":-13.039206,"eighty":-6.374893,"marketCap":25655005},{"date":"2025-11-07","current":-8.524725,"twenty":-14.481047,"median":-12.845746,"eighty":-6.381675,"marketCap":31616021},{"date":"2025-11-14","current":-9.460613,"twenty":-14.381444,"median":-12.652286,"eighty":-6.415584,"marketCap":35086992},{"date":"2025-11-21","current":-5.852155,"twenty":-14.312928,"median":-12.458826,"eighty":-6.415584,"marketCap":30182359},{"date":"2025-11-28","current":-7.071353,"twenty":-14.306662,"median":-12.304058,"eighty":-6.374893,"marketCap":36470350},{"date":"2025-12-01","current":-7.071353,"twenty":-14.293061,"median":-12.284712,"eighty":-6.374893,"marketCap":36470350}],"updateTime":1774641609833},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"APUS\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2622089178","title":"Apimeds Pharmaceuticals US Challenges Disputed Boardroom Power Shift","url":"https://stock-news.laohu8.com/highlight/detail?id=2622089178","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622089178?lang=en_us&edition=fundamental","pubTime":"2026-03-27 05:18","pubTimestamp":1774559937,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) just unveiled an update. On March 20, 2026, Inscobee Inc. and Apimeds Inc. (Apimeds Korea) attempted b...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-us-challenges-disputed-boardroom-power-shift?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-us-challenges-disputed-boardroom-power-shift?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4234","PW","BK4139","BK4084","APUS"],"gpt_icon":0},{"id":"2622990218","title":"BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622990218","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622990218?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:52","pubTimestamp":1774558375,"startTime":"0","endTime":"0","summary":"BRIEF-Apimeds Pharmaceuticals Us Inc Vin Menon Continues To Serve As The Company’S Chief Executive OfficerApimeds Pharmaceuticals US Inc APUS.A:APIMEDS PHARMACEUTICALS US INC: VIN MENON CONTINUES TO SERVE AS THE COMPANY’S CHIEF EXECUTIVE OFFICERAPIMEDS PHARMACEUTICALS US INC: ERICK FRIM CONTINUES TO SERVE AS THE COMPANY’S CHIEF FINANCIAL OFFICERAPIMEDS PHARMACEUTICALS US:DOES NOT RECOGNIZE ALLEGED APPOINTMENT OF YOUNGJIK CHO AS ONE OF THE DIRECTORS MADE IN CONNECTION WITH STOCKHOLDER CONSENTSource text: [ID:n0001213900-26-034786]Further company coverage: APUS.A","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E156:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2622899776","title":"Apimeds Pharmaceuticals US Inc: Vin Menon Continues to Serve as the Company’s Chief Executive Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899776","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899776?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:49","pubTimestamp":1774558177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E156:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2622899093","title":"Apimeds Pharmaceuticals US:Does Not Recognize Alleged Appointment of Youngjik Cho as One of the Directors Made in Connection With Stockholder Consent","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899093","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899093?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:49","pubTimestamp":1774558177,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nFWN40E156:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2622899793","title":"Apimeds Pharmaceuticals US plans emergency Delaware Chancery Court action; seeks TRO on disputed board consent","url":"https://stock-news.laohu8.com/highlight/detail?id=2622899793","media":"Reuters","labels":["policyRegulatory","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622899793?lang=en_us&edition=fundamental","pubTime":"2026-03-27 04:46","pubTimestamp":1774557999,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US said it will file an emergency action in the Delaware Court of Chancery under 8 Del. C. § 225 challenging a written-consent effort that it says unlawfully replaced its board.The company said it will seek a declaration that the consent is void and request a temporary restraining order to prevent the purported new directors from taking corporate actions.Apimeds Pharmaceuticals US said the disputed consent relied on 6,416,365 shares that it says are subject to an irrevocable proxy granted under a December 1, 2025 stockholder support and lock-up agreement.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the E","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260326:nNDL5KxP38:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"policyRegulatory,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2622702020","title":"BRIEF-Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2622702020","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622702020?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:20","pubTimestamp":1774437642,"startTime":"0","endTime":"0","summary":"BRIEF-Apimeds Pharmaceuticals Appoints Youngjik Cho As Chairman Of BoardMarch 25  - Apimeds Pharmaceuticals US Inc APUS.A:APIMEDS PHARMACEUTICALS - APPOINTS YOUNGJIK CHO AS CHAIRMAN OF THE BOARD - SEC FILINGAPIMEDS PHARMACEUTICALS- ON MAR 20, REMOVES ELONA KOGAN, JAKAP KOO, CAROL O'DONNELL, BENNETT WEINTRAUB AS DIRECTORS EFFECTIVE IMMEDIATELY - SEC FILINGAPIMEDS PHARMACEUTICALS US INC - REMOVES DR. VIN MENON AS CEO EFFECTIVE IMMEDIATELY - SEC FILINGAPIMEDS PHARMACEUTICALS US INC - APPOINTS YOUNGJIK CHO AS CEO AND JUNYOUNG YU AS SECRETARY EFFECTIVE IMMEDIATELY - SEC FILINGFurther company coverage: APUS.A ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL8N40D13L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2622302044","title":"Corrected-Apimeds Pharmaceuticals (Not 'Apimeds Korea') - Appoints Youngjik Cho as Chairman of the Board - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622302044","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622302044?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:20","pubTimestamp":1774437641,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nL8N40D13L:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2622356020","title":"Apimeds Pharmaceuticals US Inc - Appoints Mr. Cho as CEO and Mr. Yu as Secretary Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622356020","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622356020?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:08","pubTimestamp":1774436907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0UQ:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2622020354","title":"Apimeds Pharmaceuticals US Inc - Removes DR. Vin Menon as CEO Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020354","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020354?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:08","pubTimestamp":1774436907,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0UQ:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2622020330","title":"Apimeds Pharmaceuticals- on Mar 20, Removes Elona Kogan, Jakap Koo, Carol O'donnell, Bennett Weintraub as Directors Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2622020330","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622020330?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:08","pubTimestamp":1774436907,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nFWN40D0UQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2622027019","title":"Apimeds Pharmaceuticals US removes CEO Vin Menon and CFO Erick Frim; Youngjik Cho takes over as CEO and board chair","url":"https://stock-news.laohu8.com/highlight/detail?id=2622027019","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622027019?lang=en_us&edition=fundamental","pubTime":"2026-03-25 19:02","pubTimestamp":1774436575,"startTime":"0","endTime":"0","summary":"Majority stockholders delivered a written consent removing directors Elona Kogan, Jakap Koo, Carol O'Donnell and Dr. Bennett Weintraub, effective immediately.The same action appointed Youngjik Cho, Minguk Ji and Junyoung Yu as directors, effective immediately, with Minguk Ji and Junyoung Yu identified as independent.Following the board changes, the board removed Vin Menon as chief executive officer and appointed Youngjik Cho as chief executive officer and chairman, effective immediately.Minguk Ji and Junyoung Yu joined the audit, compensation, and nominating and corporate governance committees, with Junyoung Yu chairing the audit and nominating and corporate governance committees and Minguk Ji chairing the compensation committee.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted a","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260325:nNDL63zY8S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2621906268","title":"Apimeds Pharmaceuticals US readies Delaware Court of Chancery action over Inscobee board takeover attempt","url":"https://stock-news.laohu8.com/highlight/detail?id=2621906268","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621906268?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:30","pubTimestamp":1774355451,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US said Inscobee and its subsidiary Apimeds filed an amended Schedule 13D asserting they removed four directors and installed three replacements by written consent.The company said the consent used 6,416,365 shares subject to an irrevocable proxy and was executed without authorization.MindWave and Apimeds Pharmaceuticals US plan to file an emergency action in the Delaware Court of Chancery under 8 Del. C. § 225 seeking a declaration that the consent is void and requesting a temporary restraining order.Apimeds Pharmaceuticals US said it also engaged legal counsel in South Korea to pursue remedies under Korean law related to Inscobee’s actions.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"ab6e84fb0542480d9cf75cb6a9fe5601","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260324:nNDLb7n3X4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2621106299","title":"Press Release: Apimeds Pharmaceuticals US Inc. Announces Material Breach of Merger Agreement by Inscobee Inc. (KS:006490) and Apimeds Inc.; Prepares Filing Emergency Action in Delaware Court of Chancery","url":"https://stock-news.laohu8.com/highlight/detail?id=2621106299","media":"Dow Jones","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621106299?lang=en_us&edition=fundamental","pubTime":"2026-03-24 20:30","pubTimestamp":1774355400,"startTime":"0","endTime":"0","summary":"MATAWAN, N.J. & SEOUL, South Korea----March 24, 2026--. MindWave Innovations Inc., a Delaware corporation and wholly owned subsidiary of Apimeds Pharmaceuticals US, Inc.  , today announced that on March 20, 2026, Inscobee Inc.  and its wholly owned subsidiary Apimeds Inc. , in concert with certain other stockholders, filed an Amendment No. 2 to Schedule 13D with the Securities and Exchange Commission purporting to effect a hostile takeover of the Company's Board of Directors by written consent.Inscobee claims to have removed all four sitting directors of APUS and installed three hand-picked replacements without notice to the Company, without authorization from the Company as holder of an irrevocable proxy over Inscobee's shares, and in direct violation of the Stockholder Support and Lock-Up Agreement that Inscobee itself signed on December 1, 2025.The Company considers these actions void and of no legal effect.Inscobee's actions represent a calculated breach of the contractual framewor","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"8603dabb40994e59ac78c04c930c0d49","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2621637357","title":"Top Executive Makes Notable Move With American Public Education Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2621637357","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2621637357?lang=en_us&edition=fundamental","pubTime":"2026-03-21 10:02","pubTimestamp":1774058525,"startTime":"0","endTime":"0","summary":"New insider activity at American Public Education ( ($APEI) ) has taken place on March 20, 2026. Nuno S. Fernandes, President of APUS at American P...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-notable-move-with-american-public-education-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/insider-trading/top-executive-makes-notable-move-with-american-public-education-stock-insider-trading-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APUS","BK4204","APEI","BK4139"],"gpt_icon":0},{"id":"2620149236","title":"Apimeds Pharmaceuticals Sets March Effective Date for Reverse Split","url":"https://stock-news.laohu8.com/highlight/detail?id=2620149236","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620149236?lang=en_us&edition=fundamental","pubTime":"2026-03-17 05:08","pubTimestamp":1773695317,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals US, Inc. ( ($APUS) ) just unveiled an update. On December 1, 2025, Apimeds Pharmaceuticals US, Inc. obtained written consen...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-sets-march-effective-date-for-reverse-split?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/apimeds-pharmaceuticals-sets-march-effective-date-for-reverse-split?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["APUS","BK4139"],"gpt_icon":0},{"id":"2620491428","title":"Apimeds Pharmaceuticals US approves 1-for-10 reverse stock split","url":"https://stock-news.laohu8.com/highlight/detail?id=2620491428","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620491428?lang=en_us&edition=fundamental","pubTime":"2026-03-17 04:35","pubTimestamp":1773693305,"startTime":"0","endTime":"0","summary":"Apimeds said shareholders approved a 1-for-10 reverse stock split of its common stock. The reverse split is expected to be filed in Delaware on or about March 25, 2026. The reverse split is set to take effect at 12:01 a.m. ET on March 26, 2026. Apimeds expects its shares to begin trading on a split-adjusted basis on NYSE American under the symbol APUS at the open on March 26, 2026. The post-split CUSIP for the common stock is expected to be 03771D201.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Apimeds Pharmaceuticals US Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 16, 20","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260316:nNDL7nV4Kn:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2610796786","title":"Apimeds, FDA to Discuss Bee Venom Treatment for Osteoarthritis","url":"https://stock-news.laohu8.com/highlight/detail?id=2610796786","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610796786?lang=en_us&edition=fundamental","pubTime":"2026-02-12 06:48","pubTimestamp":1770850080,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals is set to discuss a treatment for osteoarthritis using bee venom at a Type C meeting with the Food and Drug Administration.The pharmaceutical company, along with L kahi Therapeutics, said Wednesday that the meeting will be held May 4, and represents an important step in its U.S. regulatory strategy for the treatment, LT-100.LT-100 is pure honeybee venom originally developed and approved in South Korea, the companies said. Apimeds and L kahi plan to advance the program in the U.S. by integrating historical data with development standards.\"LT-100 has broad therapeutic potential, and we believe that updating the route of administration to reflect current clinical best practices, while reducing burden for patients and providers, positions the program well for continued progress,\" President of Apimeds and Chief Executive Officer of L kahi Therapeutics Erik Emerson said.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2610964508","title":"Apimeds Pharmaceuticals confirms FDA Type C meeting for osteoarthritis candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=2610964508","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610964508?lang=en_us&edition=fundamental","pubTime":"2026-02-12 05:55","pubTimestamp":1770846914,"startTime":"0","endTime":"0","summary":"Apimeds Pharmaceuticals (APUS) and Lundefinedkahi Therapeutics announced that the FDA Division of Anesthesiology, Addiction Medicine and Pain Medic...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/apimeds-pharmaceuticals-confirms-fda-type-c-meeting-for-osteoarthritis-candidate-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/apimeds-pharmaceuticals-confirms-fda-type-c-meeting-for-osteoarthritis-candidate-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2610961299","title":"Apimeds Pharmaceuticals and LŌKahi Therapeutics Announce FDA Type C Meeting Scheduled for Lt‑100 (Apitox)","url":"https://stock-news.laohu8.com/highlight/detail?id=2610961299","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2610961299?lang=en_us&edition=fundamental","pubTime":"2026-02-12 05:51","pubTimestamp":1770846660,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260211:nTUA1ZZH0C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"gpt_icon":0},{"id":"2602549710","title":"Amex Halt  Add Info Lst 1.990000","url":"https://stock-news.laohu8.com/highlight/detail?id=2602549710","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602549710?lang=en_us&edition=fundamental","pubTime":"2026-01-12 23:10","pubTimestamp":1768230650,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260112:nAQN2LHBNK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","APUS"],"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":35,"code":"91000000","status":"200"}]}}